FDA OKs return of Primatene Mist asthma inhaler
A new version of the once-popular asthma inhaler Primatene Mist will soon return to U.S. stores.
The Food and Drug Administration approved the over-the-counter aerosol inhaler late Wednesday. It’s for temporary relief of mild, intermittent asthma symptoms in people ages 12 and older
The original Primatene Mist was discontinued seven years ago because the inhaler’s ozone-depleting propellant had been banned.
The new product developed by Amphastar Pharmaceuticals uses a safer propellant.